Replimune (REPL) Shareholder's Equity Growth (3y) (2021 - 2025)
Replimune (REPL) Shareholder's Equity Growth (3y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Replimune |
780.01 Mn |
510.88 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-29.28% |
| Sep 30, 2025 |
-11.82% |
| Jun 30, 2025 |
-6.37% |
| Mar 31, 2025 |
0.37% |
| Dec 31, 2024 |
3.31% |
| Sep 30, 2024 |
-5.87% |
| Jun 30, 2024 |
-3.80% |
| Mar 31, 2024 |
-9.11% |
| Dec 31, 2023 |
-6.53% |
| Sep 30, 2023 |
21.18% |
| Jun 30, 2023 |
22.77% |
| Mar 31, 2023 |
44.58% |
| Dec 31, 2022 |
44.44% |
| Sep 30, 2022 |
47.11% |
| Jun 30, 2022 |
46.62% |
| Mar 31, 2022 |
43.95% |
| Dec 31, 2021 |
45.09% |
| Sep 30, 2021 |
45.00% |
| Jun 30, 2021 |
143.17% |
| Mar 31, 2021 |
170.39% |
